Key Takeaways
- Commission III of the Indonesian House of Representatives has included the Draft Law on Narcotics and Psychotropics in the 2025-2029 priority National Legislation Program.
- Suyudi Ario Seto, Head of the National Narcotics Agency, stated the agency is considering banning the circulation of vapes after finding indications of narcotic contents.
- Hazardous substances discovered in vapes by the National Narcotics Agency include methamphetamine and the anaesthetic etomidate.
- Lawmaker Rudianto Lallo stated the agency's plan to ban the circulation of vapes is highly likely to be accommodated in the draft law currently under review.
2Firsts, April 10, 2026
According to Beritasatu, Commission III of the Indonesian House of Representatives (DPR) has opened the option to revise the Draft Law on Narcotics and Psychotropics following discussions on banning electronic cigarettes in Indonesia.
Rudianto Lallo, a member of Commission III of the DPR, stated that the Draft Law on Narcotics and Psychotropics has been included in the 2025-2029 priority National Legislation Program (Prolegnas).
He noted that the discussion of the bill is currently in the stage of gathering public opinions.
Therefore, various inputs, including the National Narcotics Agency's (BNN) plan to ban the circulation of vapes, are highly likely to be accommodated in the regulation.
Suyudi Ario Seto, Head of the National Narcotics Agency, previously revealed that the agency is considering banning the circulation of vapes after finding indications of narcotic contents in the products.
The findings include substances such as methamphetamine and the anaesthetic etomidate, which have the potential for abuse.
Rudianto expressed concern over the discovery of hazardous substances suspected to be narcotics in vapes, suggesting this could become a new loophole for traditional drug distribution.
He stated that the agency's actions serve as a preventive measure to anticipate potential drug abuse through vapes. Meanwhile, he also emphasised the importance of comprehensive scientific studies before such policies are adopted.
Image Source: Beritasatu
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
